This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Branham Law, LLP Announces Investigation Of Tellabs, Inc. For Alleged False And Misleading Statements

Branham Law, LLP announces that it has launched an investigation for possible violations of federal law relating to alleged false and misleading statements made by Tellabs, Inc. ( NASDAQ:TLAB).

Investors purchasing Tellabs, Inc. shares between October 26, 2010 and April 26, 2011, or anyone with information relating to the allegations at hand are encouraged to contact Trey Branham, Managing Partner of Branham Law, LLP at 1-877-722-5910 or tbranham@branham-law.com. The investigation concerns allegations that Tellabs and certain of its executives made false and misleading statements and omissions relating to material adverse facts about Tellabs operations, business and prospects between October 26, 2010 and April 26, 2011.

Massive drops in revenue for the 12 month period ending December 30, 2011 apparently caused shares of Tellabs, Inc. ( NASDAQ:TLAB) to fall from their October 2010 highs of $7.84 per share to August 2011 lows of $3.69 per share. The slide continues and on January 25, 2013, shares of Tellabs closed at $2.29 per share.

"We are very concerned about the apparent relationship between Tellabs statements and apparent omissions and the dramatic decline in shareholder value," said attorney Trey Branham.



Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs